HOME >> MEDICINE >> NEWS
Sniffing Out The Promise Of Anti-Angiogenesis Therapy

ATLANTA, May 16, 1999 -- A team of USC scientists led by Parkash Gill, M.D., have shown in a human clinical trial that a small peptide, in the form of a nose drop, may be a successful anti-angiogenesis treatment.

Gill's data on the anti-angiogenesis peptide IM862 in the treatment of Kaposi's Sarcoma (KS)-the most common cancer associated with HIV-will be presented at the annual meeting of the American Society of Clinical Oncology, and will be featured in a press conference on novel cancer therapies on Sunday, May 16, at 11 a.m.

In Phase II of the clinical trial of IM862-from which the data presented were taken-Gill, a professor of medicine and pathology at the University of Southern California School of Medicine, along with Peter Brooks, Ph.D., Jeffrey Weber, M.D., Ph.D., and Anil Tulpule, M.D., all from USC, treated 35 patients with an intranasal solution administered as a nose drop of IM862. They found that 37 percent of the patients showed a major response-either complete resolution of the KS lesions (4 patients) or partial reduction in tumor size (9 patients)-within six weeks of beginning treatment. In another 17 patients, the disease has not progressed for six months or longer.

"All this occurred with very few side effects," says Gill, "which were limited mostly to mild headaches."

IM862-now well into Phase III clinical trials-is among the first anti-angiogenesis drugs to get to this phase all on its own, says Gill. "Most of the other anti-angiogenic drugs are combined with chemotherapy," he notes. "This may end up being the way this family of drugs will be developed." (The chemicals which started the anti-angiogenesis debate-angiostatin and endostatin-have not yet reached Phase I trials.)

IM862, a thymic dipeptide, a small protein, was developed by Cytran, Inc., a private held company located in Kirkland, Wash. It does not go after tumor cells directly-in fact, says Gill, "it is not cytotoxic to any tumor cells." It inhibits blood ves
'"/>

Contact: Lori Olowinstein
oliwenst@usc.edu
323-442-2830
University of Southern California
17-May-1999


Page: 1 2 3 4

Related medicine news :

1. Promise of bladder pacemaker for people with spinal cord injury
2. Promise for helping adults with dyslexia
3. Promise of stem cells amplified
4. Promise of laparoscopic liver resection for liver cancer explored in unique program
5. Anti-Depressant Drug Shows Promise As Weight-Loss Treatment
6. Treatment-Resistant Depression: Results of Latest Electromagnetic Stimulation Study Show Promise
7. Alga-Based Compound Promises Less Bleeding On The Battlefield
8. Therapy Developed At Cedars-Sinai Medical Center Shows Promise In Preventing Rejection Of Transplanted Organs
9. New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease
10. "Plugs" For Drugs Promise Mightier Medicines
11. DNA-Based Cancer Vaccine Shows Promise To Successfully Treat Melanoma In Mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... ... TIME For Kids (TFK) revealed the first-ever list of the World’s ... that are tailored to the interests of kids. The list identifies The Children’s Museum ... TIME for Kids gathered nominations from its network of TFK Kid Reporters ...
(Date:12/5/2019)... ... December 05, 2019 , ... HealthCareMandA.com is hosting an interesting ... on Thursday, December 12, 2019, at 1:00 PM ET. , Private equity firms ... firms are scrambling to assemble regional platforms with enough scale and talent to ...
(Date:12/4/2019)... ... December 04, 2019 , ... A November 12 ... cities offer them as public transit options. The article highlighted the life-changing or life-ending ... confined to a bed to a rider fatality after an incident with a vehicle. ...
(Date:12/4/2019)... ... ... While the holidays are a time for joy and sharing, they can ... Service specialists. , “There are many behavioral and logistical changes you ... Joyce Cavanagh, AgriLife Extension specialist in family economics, College Station. , Prioritize and plan ...
(Date:12/2/2019)... ... 02, 2019 , ... TrialScope, the global leader in clinical ... American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch ... inform patients, caregivers, the public, patient advocacy groups and healthcare professionals (HCPs) about ...
Breaking Medicine News(10 mins):
(Date:12/4/2019)... ... 2019 , ... The Harm Reduction Institute (HRI) as a part of the ... rehab center and non-profit Intensive outpatient after care (IOP) , has officially ... distributed Naloxone amongst members of the own community in Orange County, CA. , ...
(Date:12/4/2019)... ... December 04, 2019 , ... Intelligent.com, a ... Top 17 Master's in Organizational Psychology Degree Programs for 2020. The comprehensive research ... the nation. Each program is evaluated based on curriculum quality, graduation rate, reputation, ...
(Date:12/2/2019)... ... December 02, 2019 , ... TopConsumerReviews.com ... by Native Remedies aimed at supporting Women’s Fertility and healthy natural ovulation. , ... harder for some women than for others. Factors like weight, medical conditions, age, ...
Breaking Medicine Technology:
Cached News: